DEA Removes Fenfluramine From Controlled Substances List
The Drug Enforcement Administration is removing fenfluramine from schedule IV of the Controlled Substances Act, it said in a notice of the final rule in the Dec. 23 Federal Register. The DEA said the drug has no abuse potential. The…
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
removal eliminates “the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule IV controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, engage in research, import, export, conduct instructional activities or chemical analysis with, or possess) or propose to handle fenfluramine,” the DEA said. The delisting is effective Dec. 23.